Ethnicity and socioeconomic status predict initial continuous positive airway pressure compliance in New Zealand adults with obstructive sleep apnoea

Internal Medicine Journal

Volumn 42, Issue 6, 2012, Pages

  Campbell, A ^a   Neill, A ^a   Lory, R ^a  

^a UNIVERSITY OF OTAGO WELLINGTON   (New Zealand)

Author keywords

Continuous positive airway pressure; Ethnic group; Obstructive sleep apnoea; Patient compliance; Social class

Indexed keywords

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; EPWORTH SLEEPINESS SCALE; ETHNIC DIFFERENCE; ETHNICITY; EUROPE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SLEEP APNEA SYNDROME; SOCIAL STATUS; TREATMENT DURATION;

ADULT; AGED; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SLEEP APNEA, OBSTRUCTIVE; SOCIAL CLASS;

EID: 84862540533     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2010.02360.x     Document Type: Article

References (54)

1. Lavie L, Lavie P. Smoking interacts with sleep apnea to increase cardiovascular risk. Sleep Med 2008; 9: 247-53.
2. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S etal. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep heart health study. JAMA 2000; 283: 1829-36.
3. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-84.
4. Marin J, Carrizo S, Vincente E, Agusti AG. Long term cardiovascular outcomes in men with obstructive sleep apnoea hypopnoea with or without treatment with continuous positive airway pressure; an observational study. Lancet 2005; 365: 1046-53.
5. Artz M, Young T, Finn L, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005; 172: 1447-51.
6. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005; 353: 2034-41.
7. Findley L, Unverzagt M, Suratt P. Automobile accidents involving patients with obstructive sleep apnea. Am Rev Respir Dis 1988; 138: 337-40.
8. Young T, Blustein J, Finn L, Palta M. Sleep-disordered breathing and motor vehicle accidents in a population based sample of employed adults. Sleep 1997; 20: 608-13.
9. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-5.
10. Bearpark H, Elliott L, Grunstein R, Hedner J, Cullen S, Schneider H etal. Occurrence and correlates of sleep disordered breathing in the Australian town of Busselton: a preliminary analysis. Sleep 1993; 16: 3-5.
11. Ip MS, Lam B, Tang LC, Lauder IJ, Ip TY, Lam WK. A community study of sleep-disordered breathing in middle-aged Chinese women in Hong Kong: prevalence and gender differences. Chest 2004; 125: 127-34.
12. Scharf SM, Seiden L, DeMore J, Carter-Pokras O. Racial differences in clinical presentation of patients with sleep-disordered breathing. Sleep Breath 2004; 8: 173-83.
13. O'Connor GT, Lind BK, Lee ET, Nieto J, Redline S, Samet JM etal. Variation in symptoms of sleep-disordered breathing with race and ethnicity: the sleep health heart study. Sleep 2003; 26: 74-9.
14. Mihaere KM, Harris R, Gander PH, Reid PM, Purdie G, Robson B etal. Obstructive sleep apnoea in New Zealand adults: prevalence and risk factors among Maori and non-Maori. Sleep 2009; 32: 949-56.
15. Harris R. Obstructive Sleep Apnoea Syndrome: Symptoms and Risk Factors among Māori and Non-Māori Adults in Aotearoa. Masters of Public Health. Wellington: University of Otago Wellington; 2003.
16. Baldwin DR, Kolbe J, Troy K, Belcher J, Frankel A, Eaton T etal. Comparative clinical and physiological features of Maori, Pacific Islanders and Europeans with sleep related breathing disorders. Respirology 1998; 3: 253-60.
17. Frith RW, Cant BR. Obstructive sleep apnoea in Auckland: diagnosis and treatment. NZ Med J 1985; 98: 745-8.
18. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981; 1: 862-5.
19. Kushida CA, Littner MR, Hirschkowitz M, Morgenthaler TI, Alessi CA, Bailey D etal. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep related breathing disorders. Sleep 2006; 29: 375-80.
20. Scott HM, Scott WG, Mihaere K, Gander PH. Economic evaluation of the treatment of obstructive sleep apnoea syndrome in Aoteraroa/New Zealand. Int Rev Bus Res Papers 2007; 3: 237-61.
21. Pepin J, Leger P, Veale D, Langevin B, Robert D, Levy P. Side effects of nasal continuous positive airway pressure in sleep apnea syndrome. Chest 1995; 107: 375-81.
22. Richards G, Cistulli P, Ungar R, Berthon-Jones M, Sullivan C. Mouth leak with nasal continuous positive airway pressure increases nasal airway resistance. Am J Respir Crit Care Med 1996; 154: 182-6.
23. Neill A, Hla W, Bannan S, Beasley CR, Weatherall M, Campbell AJ. Humidified nasal continuous positive airway pressure in obstructive sleep apnoea. Eur Respir J 2003; 22: 258-61.
24. Massie C, Hart R, Peralez K, Richards G. Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest 1999; 116: 403-8.
25. Bakker J, Campbell A, Neill A. Randomized controlled trial comparing flexible and continuous positive airway pressure delivery: effects on compliance, objective and subjective sleepiness and vigilance. Sleep 2010; 33: 523-9.
26. Marshall NS, Neill AM, Campbell AJ. Randomised trial of compliance with flexible (C-Flex) and standard continuous positive airway pressure for severe obstructive sleep apnea. Sleep Breath 2008; 12: 393-6.
27. TM) versus CPAP in OSA patients. Sleep Breath 2008; 13: 73-7.
28. Leidag M, Hader C, Keller T, Meyer Y, Rasche K. Mask leakage in continuous positive airway pressure and C-Flex. J Physiol Pharmacol 2008; 59(Suppl 6): 401-6.
29. Weaver T, Maislin G, Dinges DF, Bloxham T, George CF, Greenberg H etal. Relationship between hours of CPAP use and achieving normal levels of sleepiness and functioning. Sleep 2007; 30: 711-19.
30. Patel SR, White DP, Malhotra A, Stanchina ML, Ayas NT. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med 2003; 163: 565-71.
31. Marshall NS, Barnes M, Travier N, Campbell AJ, Pierce RJ, McEvoy RD etal. Continuous positive airway pressure reduces daytime sleepiness in mild to moderate obstructive sleep apnoea: a meta-analysis. Thorax 2006; 61: 430-4.
32. Monserrat JM, Ferrer M, Hernandez L, Farre R, Vilagut G, Navajas D etal. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome. A randomized controlled study with an optimzed placebo. Am J Respir Crit Care Med 2001; 164: 608-13.
33. Gentles D, Metcalfe P, Dyall L, Scragg R, Black P, Schaaf D etal. Blood pressure prevalences and levels for a multicultural population in Auckland, New Zealand: results from the diabetes heart and health survey 2002/3. NZ Med J 2006; 119: U2318.
34. NZ Health Information Service, Maori Health. Health status indicators: cardiovascular disease. [Cited 2010 Feb 3]. Available from URL:.
35. Gerritsen S, Stefanogiannis N, Galloway Y. A Portrait of Health-Key Results of the 2006/7 New Zealand Health Survey: Chapter 3 Health Conditions. Wellington: Ministry of Health; 2008; [Cited 2010 Feb 3]. Available from URL:.
36. White P, Salmond C, Crampton P, Gunston J, Atkinson J. Atlas of Socio-Economic Distribution in New Zealand Nzdep2006. Wellington: Ministry of Health; 2006.
37. Salmond C, Crampton P, Atkinson J. Nzdep2006 Index of Deprivation: User's Manual. Wellington: Department of Public Health, University of Otago; 2007.
38. Preston SH, Taubman P. Socioeconomic differences in adult mortality and health status. In: Martin LG, Preston SH, eds. Demography of Aging. Washington (DC): National Academy Press; 1994; 279-318.
39. Ministry of Health. Ethnicity Data Protocols for the Health and Disability Sector. Wellington: Ministry of Health; 2004.
40. Kushida CA, Chediak A, Berry RB, Brown LK, Gozal D, Iber C etal. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnoea. J Clin Sleep Med 2008; 4: 157-71.
41. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-45.
42. Statistics New Zealand. Census data. 2006. [cited 2009 Dec 2]. Available from URL:.
43. Waldhorn R, Herrick T, Nguyen M, O'Donnell A, Sodero J, Potolicchio S. Long term compliance with nasal continuous positive airway pressure therapy of obstructive sleep apnea. Chest 1990; 97: 33-8.
44. Engleman HM, Asgari-Jirhandeh N, McLeod AL, Ramsay CF, Deary IJ, Douglas NJ. Self-reported use of CPAP and benefits of CPAP therapy. A patient survey. Chest 1996; 109: 1470-76.
45. Engleman HM, Wild MR. Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS). Sleep Med Rev 2003; 7: 81-99.
46. Weaver TE, Maislin G, Dinges DF, Younger J, Cantor C, McCloskey S etal. Self-efficacy in sleep apnea: instrument development and patient perceptions of obstructive sleep apnea risk, treatment benefit, and volition to use continuous positive airway pressure. Sleep 2003; 26: 727-32.
47. Aloia MS, Arnedt JT, Stepnowsky C, Hecht J, Borrelli B. Predicting treatment adherence in obstructive sleep apnea using principles of behavior change. J Clin Sleep Med 2005; 1: 346-53.
48. Poulet C, Veale D, Arnol N, Levy P, Pepin JL, Tyrrell J. Psychological variables as predictors of adherence to treatment by continuous positive airway pressure. Sleep Med 2009; 10: 993-9.
49. Meslier N, Lebrun T, Grillier-Lanoir V, Rolland N, Hendrick C, Sailly J-C etal. A French survey of 3225 patients treated with CPAP for OSA: benefits, tolerance, compliance and quality of life. Eur Respir J 1998; 12: 185-92.
50. Platt AB, Field SH, Asch DA, Chen Z, Patel NP, Gupta R etal. Neighborhood of residence is associated with daily adherence to CPAP therapy. Sleep 2009; 32: 799-806.
51. Simon-Tuval T, Reuveni H, Greenberg-Dotan S, Oksenberg A, Tal A, Tarasiuk A. Low socioeconomic status is a risk factor for CPAP acceptance among adult OSAS patients requiring treatment. Sleep 2009; 32: 545-52.
52. Salmond C, Crampton P, King P, Waldegrave C. NZiDep: a New Zealand index of socioeconomic deprivation for individuals. Soc Sci Med 2006; 62: 1474-85.
53. McArdle N, Devereux G, Heidarnejad H, Engleman HM, MacKay TW, Douglas NJ. Long-term use of CPAP therapy for sleep apnea/hypopnoea syndrome. Am J Respir Crit Care Med 1999; 159: 1108-14.
54. Budhiraja R, Parthasarathy S, Drake CL, Roth T, Sharief I, Budhiraja P etal. Early CPAP use identifies subsequent adherence to CPAP therapy. Sleep 2007; 30: 320-24.